HSR22-124: Real-World Outcomes Among Patients With Stage IV Epidermal Growth Factor Receptor (EGFR) Mutated Non-Small Cell Lung Cancer Treated With EGFR Tyrosine Kinase Inhibitors Versus Immunotherapy With or Without Chemotherapy in First-line Setting
| Autor: | Jon Apple, Rahul Shenolikar, Kevin De Silva, Ping Sun, Alexander Spira |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Journal of the National Comprehensive Cancer Network. 20:HSR22-124 |
| ISSN: | 1540-1413 1540-1405 |
| DOI: | 10.6004/jnccn.2021.7187 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|